ガンマナイフの世界市場見通し2017-2026

◆英語タイトル:Gamma Knife - Global Market Outlook (2017-2026)
◆商品コード:SMRC803030
◆発行会社(リサーチ会社):Stratistics MRC
◆発行日:2018年3月
◆ページ数:要問い合わせ
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥456,500見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥577,500見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、ガンマナイフの世界市場について調査・分析し、ガンマナイフの世界市場規模、市場動向、セグメント別市場分析、市場環境分析、関連企業情報などを含め、以下の構成でお届けいたします。
・エグゼクティブサマリー
・序文
・市場動向分析
・市場環境分析(ポーターのファイブフォース分析)
・ガンマナイフの世界市場規模:人体部分別分析
・ガンマナイフの世界市場規模:症状別分析
・ガンマナイフの世界市場規模:エンドユーザー別分析
・ガンマナイフの世界市場規模:地域別分析
・主要な市場開発
・企業プロファイル
【レポートの概要】

According to Stratistics MRC, the Global Gamma Knife Market is accounted for $193.71 million in 2017 and is expected to reach $475.86 million by 2026 growing at a CAGR of 10.5% during the forecast period. Factors such as growing occurrence of cancer, brain tumors, and other neurological diseases, increasing preference for minimally invasive surgeries (MIS) and expanding implementation of these instruments in surgery centers are driving the market growth. However, huge price of implementation, lack of trained manpower and strict government rules and regulations are hindering the growth of the market.

Gamma Knife is a radiation therapies which use computerized treatment planning software to facilitate physicians establish and irradiate minute targets inside the head and brain with extremely high accuracy. The treatment delivers strong radiation doses to the target area though sparing surrounding tissue.

By indication, Brain metastases are a kind of cancer which travels towards the brain before starting in other parts of the body. It is an overwhelming trouble among hundreds of thousands of individuals growing brain metastases every year in the United States. The equipment utilizes to identify and treat brain metastases have increased radically over the years. CT scans and MRIs have authorized to identify brain metastases faster and more often than ever before. The Gamma Knife has proved a powerful, minimally invasive instrument in treating brain tumors wherever in the brain, including those deep inside the structure that were earlier believed untreatable.

Asia Pacific accounted for a significant market share due to huge occurrence of brain tumor, increasing awareness between healthcare professionals concerning non-invasive treatment redundancies such as stereotactic surgeries, huge implementation of these instruments in surgery centers, and rising healthcare infrastructure.

Some of the key players in Gamma Knife Market include Elekta, Huiheng Medical Inc., Varian Medical Systems, Isotrend spol. s r.o., American Radiosurgery Inc., OZYUREK AS, Cyber Medical Corporation Limited, Nordion Inc., Masep Infini Global, Inc., ET Medical Group, American Shared Hospital Services, Hokai, Accuray Incorporated, Brainlab, GE Healthcare, Hitachi America and Philips Healthcare.

Anatomies Covered:
• Neck
• Head
• Other Anatomys

Indications Covered:
• Arteriovenous Malformation (AVM)
• Trigeminal Neuralgia
• Brain Metastases
• Movement Disorders
• Cancer
• Malignant tumors
• Vascular disorders
• Ocular diseases
• Benign tumors
• Brain Tumors
• Functional disorders
• Other Indications

End Users Covered:
• Clinics
• Hospital
• Ambulatory centers

Regions Covered:

North America
US
Canada
Mexico
Europe
Germany
UK
Italy
France
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
South America
Argentina
Brazil
Chile
Rest of South America
Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Gamma Knife Market, By Anatomy
5.1 Introduction
5.2 Neck
5.3 Head
5.4 Other Anatomys

6 Global Gamma Knife Market, By Indication
6.1 Introduction
6.2 Arteriovenous Malformation (AVM)
6.3 Trigeminal Neuralgia
6.4 Brain metastases
6.5 Movement Disorders
6.6 Cancer
6.7 Malignant tumors
6.8 Vascular disorders
6.9 Ocular diseases
6.10 Benign tumors
6.11 Brain Tumors
6.12 Functional disorders
6.13 Other Indications
6.13.1 Epilepsy
6.13.2 Pituitary Tumour
6.13.3 Parkinson’s
6.13.4 Acoustic Neuroma

7 Global Gamma Knife Market, By End User
7.1 Introduction
7.2 Clinics
7.3 Hospital
7.4 Ambulatory centers

8 Global Gamma Knife Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Elekta
10.2 Huiheng Medical Inc.
10.3 Varian Medical Systems
10.4 ISOTREND spol. s r.o.
10.5 American Radiosurgery Inc.
10.6 OZYUREK AS
10.7 Cyber Medical Corporation Limited
10.8 Nordion Inc.,
10.9 Masep Infini Global, Inc.
10.10 ET Medical Group
10.11 American Shared Hospital Services
10.12 Hokai
10.13 Accuray Incorporated
10.14 Brainlab
10.15 GE Healthcare
10.16 Hitachi America
10.17 Philips Healthcare

List Of Tables
1 Global Gamma Knife Market Outlook, By Region (2016-2026) ($MN)
2 Global Gamma Knife Market Outlook, By Anatomy (2016-2026) ($MN)
3 Global Gamma Knife Market Outlook, By Neck (2016-2026) ($MN)
4 Global Gamma Knife Market Outlook, By Head (2016-2026) ($MN)
5 Global Gamma Knife Market Outlook, By Other Anatomys (2016-2026) ($MN)
6 Global Gamma Knife Market Outlook, By Indication (2016-2026) ($MN)
7 Global Gamma Knife Market Outlook, By Arteriovenous Malformation (AVM) (2016-2026) ($MN)
8 Global Gamma Knife Market Outlook, By Trigeminal Neuralgia (2016-2026) ($MN)
9 Global Gamma Knife Market Outlook, By Brain metastases (2016-2026) ($MN)
10 Global Gamma Knife Market Outlook, By Movement Disorders (2016-2026) ($MN)
11 Global Gamma Knife Market Outlook, By Cancer (2016-2026) ($MN)
12 Global Gamma Knife Market Outlook, By Malignant tumors (2016-2026) ($MN)
13 Global Gamma Knife Market Outlook, By Vascular disorders (2016-2026) ($MN)
14 Global Gamma Knife Market Outlook, By Ocular diseases (2016-2026) ($MN)
15 Global Gamma Knife Market Outlook, By Benign tumors (2016-2026) ($MN)
16 Global Gamma Knife Market Outlook, By Brain Tumors (2016-2026) ($MN)
17 Global Gamma Knife Market Outlook, By Functional disorders (2016-2026) ($MN)
18 Global Gamma Knife Market Outlook, By Other Indications (2016-2026) ($MN)
19 Global Gamma Knife Market Outlook, By Epilepsy (2016-2026) ($MN)
20 Global Gamma Knife Market Outlook, By Pituitary Tumour (2016-2026) ($MN)
21 Global Gamma Knife Market Outlook, By Parkinson’s (2016-2026) ($MN)
22 Global Gamma Knife Market Outlook, By Acoustic Neuroma (2016-2026) ($MN)
23 Global Gamma Knife Market Outlook, By End User (2016-2026) ($MN)
24 Global Gamma Knife Market Outlook, By Clinics (2016-2026) ($MN)
25 Global Gamma Knife Market Outlook, By Hospital (2016-2026) ($MN)
26 Global Gamma Knife Market Outlook, By Ambulatory centers (2016-2026) ($MN)
27 North America Gamma Knife Market Outlook, By Country (2016-2026) ($MN)
28 North America Gamma Knife Market Outlook, By Anatomy (2016-2026) ($MN)
29 North America Gamma Knife Market Outlook, By Neck (2016-2026) ($MN)
30 North America Gamma Knife Market Outlook, By Head (2016-2026) ($MN)
31 North America Gamma Knife Market Outlook, By Other Anatomys (2016-2026) ($MN)
32 North America Gamma Knife Market Outlook, By Indication (2016-2026) ($MN)
33 North America Gamma Knife Market Outlook, By Arteriovenous Malformation (AVM) (2016-2026) ($MN)
34 North America Gamma Knife Market Outlook, By Trigeminal Neuralgia (2016-2026) ($MN)
35 North America Gamma Knife Market Outlook, By Brain metastases (2016-2026) ($MN)
36 North America Gamma Knife Market Outlook, By Movement Disorders (2016-2026) ($MN)
37 North America Gamma Knife Market Outlook, By Cancer (2016-2026) ($MN)
38 North America Gamma Knife Market Outlook, By Malignant tumors (2016-2026) ($MN)
39 North America Gamma Knife Market Outlook, By Vascular disorders (2016-2026) ($MN)
40 North America Gamma Knife Market Outlook, By Ocular diseases (2016-2026) ($MN)
41 North America Gamma Knife Market Outlook, By Benign tumors (2016-2026) ($MN)
42 North America Gamma Knife Market Outlook, By Brain Tumors (2016-2026) ($MN)
43 North America Gamma Knife Market Outlook, By Functional disorders (2016-2026) ($MN)
44 North America Gamma Knife Market Outlook, By Other Indications (2016-2026) ($MN)
45 North America Gamma Knife Market Outlook, By Epilepsy (2016-2026) ($MN)
46 North America Gamma Knife Market Outlook, By Pituitary Tumour (2016-2026) ($MN)
47 North America Gamma Knife Market Outlook, By Parkinson’s (2016-2026) ($MN)
48 North America Gamma Knife Market Outlook, By Acoustic Neuroma (2016-2026) ($MN)
49 North America Gamma Knife Market Outlook, By End User (2016-2026) ($MN)
50 North America Gamma Knife Market Outlook, By Clinics (2016-2026) ($MN)
51 North America Gamma Knife Market Outlook, By Hospital (2016-2026) ($MN)
52 North America Gamma Knife Market Outlook, By Ambulatory centers (2016-2026) ($MN)
53 Europe Gamma Knife Market Outlook, By Country (2016-2026) ($MN)
54 Europe Gamma Knife Market Outlook, By Anatomy (2016-2026) ($MN)
55 Europe Gamma Knife Market Outlook, By Neck (2016-2026) ($MN)
56 Europe Gamma Knife Market Outlook, By Head (2016-2026) ($MN)
57 Europe Gamma Knife Market Outlook, By Other Anatomys (2016-2026) ($MN)
58 Europe Gamma Knife Market Outlook, By Indication (2016-2026) ($MN)
59 Europe Gamma Knife Market Outlook, By Arteriovenous Malformation (AVM) (2016-2026) ($MN)
60 Europe Gamma Knife Market Outlook, By Trigeminal Neuralgia (2016-2026) ($MN)
61 Europe Gamma Knife Market Outlook, By Brain metastases (2016-2026) ($MN)
62 Europe Gamma Knife Market Outlook, By Movement Disorders (2016-2026) ($MN)
63 Europe Gamma Knife Market Outlook, By Cancer (2016-2026) ($MN)
64 Europe Gamma Knife Market Outlook, By Malignant tumors (2016-2026) ($MN)
65 Europe Gamma Knife Market Outlook, By Vascular disorders (2016-2026) ($MN)
66 Europe Gamma Knife Market Outlook, By Ocular diseases (2016-2026) ($MN)
67 Europe Gamma Knife Market Outlook, By Benign tumors (2016-2026) ($MN)
68 Europe Gamma Knife Market Outlook, By Brain Tumors (2016-2026) ($MN)
69 Europe Gamma Knife Market Outlook, By Functional disorders (2016-2026) ($MN)
70 Europe Gamma Knife Market Outlook, By Other Indications (2016-2026) ($MN)
71 Europe Gamma Knife Market Outlook, By Epilepsy (2016-2026) ($MN)
72 Europe Gamma Knife Market Outlook, By Pituitary Tumour (2016-2026) ($MN)
73 Europe Gamma Knife Market Outlook, By Parkinson’s (2016-2026) ($MN)
74 Europe Gamma Knife Market Outlook, By Acoustic Neuroma (2016-2026) ($MN)
75 Europe Gamma Knife Market Outlook, By End User (2016-2026) ($MN)
76 Europe Gamma Knife Market Outlook, By Clinics (2016-2026) ($MN)
77 Europe Gamma Knife Market Outlook, By Hospital (2016-2026) ($MN)
78 Europe Gamma Knife Market Outlook, By Ambulatory centers (2016-2026) ($MN)
79 Asia Pacific Gamma Knife Market Outlook, By Country (2016-2026) ($MN)
80 Asia Pacific Gamma Knife Market Outlook, By Anatomy (2016-2026) ($MN)
81 Asia Pacific Gamma Knife Market Outlook, By Neck (2016-2026) ($MN)
82 Asia Pacific Gamma Knife Market Outlook, By Head (2016-2026) ($MN)
83 Asia Pacific Gamma Knife Market Outlook, By Other Anatomys (2016-2026) ($MN)
84 Asia Pacific Gamma Knife Market Outlook, By Indication (2016-2026) ($MN)
85 Asia Pacific Gamma Knife Market Outlook, By Arteriovenous Malformation (AVM) (2016-2026) ($MN)
86 Asia Pacific Gamma Knife Market Outlook, By Trigeminal Neuralgia (2016-2026) ($MN)
87 Asia Pacific Gamma Knife Market Outlook, By Brain metastases (2016-2026) ($MN)
88 Asia Pacific Gamma Knife Market Outlook, By Movement Disorders (2016-2026) ($MN)
89 Asia Pacific Gamma Knife Market Outlook, By Cancer (2016-2026) ($MN)
90 Asia Pacific Gamma Knife Market Outlook, By Malignant tumors (2016-2026) ($MN)
91 Asia Pacific Gamma Knife Market Outlook, By Vascular disorders (2016-2026) ($MN)
92 Asia Pacific Gamma Knife Market Outlook, By Ocular diseases (2016-2026) ($MN)
93 Asia Pacific Gamma Knife Market Outlook, By Benign tumors (2016-2026) ($MN)
94 Asia Pacific Gamma Knife Market Outlook, By Brain Tumors (2016-2026) ($MN)
95 Asia Pacific Gamma Knife Market Outlook, By Functional disorders (2016-2026) ($MN)
96 Asia Pacific Gamma Knife Market Outlook, By Other Indications (2016-2026) ($MN)
97 Asia Pacific Gamma Knife Market Outlook, By Epilepsy (2016-2026) ($MN)
98 Asia Pacific Gamma Knife Market Outlook, By Pituitary Tumour (2016-2026) ($MN)
99 Asia Pacific Gamma Knife Market Outlook, By Parkinson’s (2016-2026) ($MN)
100 Asia Pacific Gamma Knife Market Outlook, By Acoustic Neuroma (2016-2026) ($MN)
101 Asia Pacific Gamma Knife Market Outlook, By End User (2016-2026) ($MN)
102 Asia Pacific Gamma Knife Market Outlook, By Clinics (2016-2026) ($MN)
103 Asia Pacific Gamma Knife Market Outlook, By Hospital (2016-2026) ($MN)
104 Asia Pacific Gamma Knife Market Outlook, By Ambulatory centers (2016-2026) ($MN)
105 South America Gamma Knife Market Outlook, By Country (2016-2026) ($MN)
106 South America Gamma Knife Market Outlook, By Anatomy (2016-2026) ($MN)
107 South America Gamma Knife Market Outlook, By Neck (2016-2026) ($MN)
108 South America Gamma Knife Market Outlook, By Head (2016-2026) ($MN)
109 South America Gamma Knife Market Outlook, By Other Anatomys (2016-2026) ($MN)
110 South America Gamma Knife Market Outlook, By Indication (2016-2026) ($MN)
111 South America Gamma Knife Market Outlook, By Arteriovenous Malformation (AVM) (2016-2026) ($MN)
112 South America Gamma Knife Market Outlook, By Trigeminal Neuralgia (2016-2026) ($MN)
113 South America Gamma Knife Market Outlook, By Brain metastases (2016-2026) ($MN)
114 South America Gamma Knife Market Outlook, By Movement Disorders (2016-2026) ($MN)
115 South America Gamma Knife Market Outlook, By Cancer (2016-2026) ($MN)
116 South America Gamma Knife Market Outlook, By Malignant tumors (2016-2026) ($MN)
117 South America Gamma Knife Market Outlook, By Vascular disorders (2016-2026) ($MN)
118 South America Gamma Knife Market Outlook, By Ocular diseases (2016-2026) ($MN)
119 South America Gamma Knife Market Outlook, By Benign tumors (2016-2026) ($MN)
120 South America Gamma Knife Market Outlook, By Brain Tumors (2016-2026) ($MN)
121 South America Gamma Knife Market Outlook, By Functional disorders (2016-2026) ($MN)
122 South America Gamma Knife Market Outlook, By Other Indications (2016-2026) ($MN)
123 South America Gamma Knife Market Outlook, By Epilepsy (2016-2026) ($MN)
124 South America Gamma Knife Market Outlook, By Pituitary Tumour (2016-2026) ($MN)
125 South America Gamma Knife Market Outlook, By Parkinson’s (2016-2026) ($MN)
126 South America Gamma Knife Market Outlook, By Acoustic Neuroma (2016-2026) ($MN)
127 South America Gamma Knife Market Outlook, By End User (2016-2026) ($MN)
128 South America Gamma Knife Market Outlook, By Clinics (2016-2026) ($MN)
129 South America Gamma Knife Market Outlook, By Hospital (2016-2026) ($MN)
130 South America Gamma Knife Market Outlook, By Ambulatory centers (2016-2026) ($MN)
131 Middle East & Africa Gamma Knife Market Outlook, By Country (2016-2026) ($MN)
132 Middle East & Africa Gamma Knife Market Outlook, By Anatomy (2016-2026) ($MN)
133 Middle East & Africa Gamma Knife Market Outlook, By Neck (2016-2026) ($MN)
134 Middle East & Africa Gamma Knife Market Outlook, By Head (2016-2026) ($MN)
135 Middle East & Africa Gamma Knife Market Outlook, By Other Anatomys (2016-2026) ($MN)
136 Middle East & Africa Gamma Knife Market Outlook, By Indication (2016-2026) ($MN)
137 Middle East & Africa Gamma Knife Market Outlook, By Arteriovenous Malformation (AVM) (2016-2026) ($MN)
138 Middle East & Africa Gamma Knife Market Outlook, By Trigeminal Neuralgia (2016-2026) ($MN)
139 Middle East & Africa Gamma Knife Market Outlook, By Brain metastases (2016-2026) ($MN)
140 Middle East & Africa Gamma Knife Market Outlook, By Movement Disorders (2016-2026) ($MN)
141 Middle East & Africa Gamma Knife Market Outlook, By Cancer (2016-2026) ($MN)
142 Middle East & Africa Gamma Knife Market Outlook, By Malignant tumors (2016-2026) ($MN)
143 Middle East & Africa Gamma Knife Market Outlook, By Vascular disorders (2016-2026) ($MN)
144 Middle East & Africa Gamma Knife Market Outlook, By Ocular diseases (2016-2026) ($MN)
145 Middle East & Africa Gamma Knife Market Outlook, By Benign tumors (2016-2026) ($MN)
146 Middle East & Africa Gamma Knife Market Outlook, By Brain Tumors (2016-2026) ($MN)
147 Middle East & Africa Gamma Knife Market Outlook, By Functional disorders (2016-2026) ($MN)
148 Middle East & Africa Gamma Knife Market Outlook, By Other Indications (2016-2026) ($MN)
149 Middle East & Africa Gamma Knife Market Outlook, By Epilepsy (2016-2026) ($MN)
150 Middle East & Africa Gamma Knife Market Outlook, By Pituitary Tumour (2016-2026) ($MN)
151 Middle East & Africa Gamma Knife Market Outlook, By Parkinson’s (2016-2026) ($MN)
152 Middle East & Africa Gamma Knife Market Outlook, By Acoustic Neuroma (2016-2026) ($MN)
153 Middle East & Africa Gamma Knife Market Outlook, By End User (2016-2026) ($MN)
154 Middle East & Africa Gamma Knife Market Outlook, By Clinics (2016-2026) ($MN)
155 Middle East & Africa Gamma Knife Market Outlook, By Hospital (2016-2026) ($MN)
156 Middle East & Africa Gamma Knife Market Outlook, By Ambulatory centers (2016-2026) ($MN)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ガンマナイフの世界市場見通し2017-2026(Gamma Knife - Global Market Outlook (2017-2026))]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆